Advertisement

Schedules, Sleep, and the Usual Suspect

This past weekend, I drove from New York City all the way to Alabama with my wife, stopping along the way in West Virginia and staying the weekend in Sewanee, Tennessee, for her 10-year college reunion. It was a gorgeous autumn drive and, after a fun weekend spent meeting my wife’s old friends, I drove down to my hometown in southeast Alabama to begin work on a movie we hope to shoot in the spring of 2007. Read More “Schedules, Sleep, and the Usual Suspect”

What We’re Reading: Thanksgiving

This week, we’d like to direct your attention to this post at www.diabetesdaily.com about handling Thanksgiving (yes, it’s almost that time already!) when you have diabetes. It contains several tips and also links to a forum where people can discuss their holiday plans. This blog entry is written by David Edelman.

(“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.) Read More “What We’re Reading: Thanksgiving”

What We’re Reading

“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.

(What’s a blog, you ask? It’s short for “weblog,” and you’re reading one right now! Learn more about blogs from our earlier post on the topic.)

This week, we’d like to direct your attention to this post at diabetes.about.com about Wal-Mart’s new generic drug program, which will offer month-long supplies of 314 of the most commonly prescribed generic drugs for $4.00 apiece. This blog is written by Debra Manzella, a writer and practicing nurse. Read More “What We’re Reading”

Public Warned About Fake OneTouch Test Strips

The U.S. Food and Drug Administration (FDA) is alerting people with diabetes to watch out for counterfeit blood glucose test strips intended for use with various models of LifeScan’s OneTouch blood glucose meters. While this announcement was originally made last Friday, October 13, additional lots of counterfeit test strips have been discovered over the past few days. Read More “Public Warned About Fake OneTouch Test Strips”

New Diabetes Drug Januvia Approved by FDA

The U.S. Food and Drug Administration (FDA) approved a new oral diabetes drug on Tuesday, October 17. The drug, sitagliptin (brand name Januvia), is manufactured by the pharmaceutical company Merck & Co., Inc., and is meant for use in people with Type 2 diabetes. Januvia is the first drug in a new class called dipeptidyl peptidase IV (or DPP-4) inhibitors to be approved. Read More “New Diabetes Drug Januvia Approved by FDA”

Better Know a Pharmacist

I’ve recently been intrigued with all of the new gadgets and advancements available for treating diabetes, but there seems to be a little something that’s been left out. Now we’ve got needles, pumps, pills, prickers, inhalers, and the like, but is there anything we’re missing? Why, yes, I think so. Last week, I went to the pharmacist to renew my prescription of insulin glargine (brand name Lantus) and this time, instead of stating the norm, I decided to spice it up and requested my insulin in “rock” form. Read More “Better Know a Pharmacist”

Accu-Chek Insulin Pump Hits U.S. Market

The Accu-Chek Spirit insulin pump, manufactured in Switzerland by Disetronic Medical Systems (a subsidiary of Roche Diagnostics Corp.), is now available in the United States. The pump “system,” which includes the Spirit insulin pump, a Palm PDA with Accu-Chek Pocket Compass software, a choice of one of three Accu-Chek blood glucose meters, and a choice of carrying case, will begin shipping on October 30. Read More “Accu-Chek Insulin Pump Hits U.S. Market”

 

The latest delivered straight to your inbox

Learn More

Newsletter

Subscribe to Stay Informed

Sign up for Free

Get the latest diabetes news and a free gift!

Learn More

Save Your Favorites